{"title": "Therapeutic potential of inhibition of the NF-B pathway in the treatment of inflammation and cancer", "author": "The Journal", "url": null, "hostname": null, "description": null, "sitename": "American Society for Clinical Investigation", "date": "2001-01-15", "cleaned_text": "Go to JCI Insight About Editors Consulting Editors For authors Publication ethics Alerts Advertising Job board Subscribe Contact Current issue Past issues By specialty COVID-19 Cardiology Gastroenterology Videos Conversations with Giants in Medicine Author's Takes Reviews Reviews View all reviews ... Review Series Lung inflammatory injury and tissue repair (Jul 2023) Immune Environment in Glioblastoma (Feb 2023) Korsmeyer Award 25th Anniversary Collection (Jan 2023) Aging (Jul 2022) Next-Generation Sequencing in Medicine (Jun 2022) New Therapeutic Targets in Cardiovascular Diseases (Mar 2022) Immunometabolism (Jan 2022) View all review series ... Viewpoint Collections In-Press Preview Commentaries Research letters Letters to the editor Editorials Viewpoint Top read articles Clinical Medicine JCI This Month Current issue Past issues Citations to this article Therapeutic potential of inhibition of the NF-B pathway in the treatment of inflammation and cancer Yumi Yamamoto, Richard B. Gaynor Yumi Yamamoto, Richard B. Gaynor Published January 15, 107(2) :135-142. https://doi.org/10.1172/JCI11914 Perspective Therapeutic potential of inhibition of the NF-B pathway in the treatment of inflammation and cancer Text PDF Abstract Authors Yumi Yamamoto, Richard B. Gaynor \u00d7 Loading citation information... Advertisement Copyright \u00a9 2023 American Society for Clinical Investigation ISSN: 0021-9738 (print), 1558-8238 (online) Sign up for email alerts "}